Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors and other biologically active compounds. Its structure supports the construction of heterocyclic frameworks common in drug design, especially for treatments targeting inflammatory diseases and certain cancers. The compound's functional groups allow for selective modifications, enabling optimization of pharmacokinetic properties in lead compounds during medicinal chemistry research.